|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
Most strikingly, spraying fresh human tissue taken from patients during cytoreductive surgery for peritoneal metastasis of colon cancer with an aqueous solution of CCAT1 FIT-PNA results in bright fluorescence in a matter of minutes.
|
31121464 |
2019 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
The long noncoding RNAs (lncRNAs) Colon Cancer-Associated Transcripts 1 and 2 (CCAT1 and CCAT2) are located in a recurrently amplified region in cancers.
|
30693526 |
2019 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
Colon-cancer-associated transcript-1 (CCAT1) was first identified in colon cancer and has subsequently been reported to perform many functions in tumor progression.
|
28549102 |
2017 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
In particular, the lncRNA CARLo-5 has a functional role in cell-cycle regulation in colon cancer, while the clinical significance and biological function of CARLo-5 in HCC remain unelucidated.
|
26433964 |
2017 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
CCAT1 has been reported to be linked with pathogenesis of malignancies including colon cancer and gastric cancer.
|
26225650 |
2015 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
It has been reported that CCAT1 is involved in the development of malignancies including colon cancer and gastric cancer.
|
26191246 |
2015 |
|
Malignant tumor of colon
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The CARLo-5, a newly identified long non-coding RNA, was found to be upregulated in colon cancer.
|
25674211 |
2014 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
Cancer-associated region long non-coding RNA (CARLo-5), a recently identified lncRNA, was initially characterized in colon cancer.
|
25129441 |
2014 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
We aimed to define and validate CCAT1 as a CC-specific biomarker, and to study CCAT1 expression across the adenoma-carcinoma sequence of CC tumorigenesis.
|
23594791 |
2013 |
|
Malignant tumor of colon
|
0.400 |
Biomarker
|
disease |
BEFREE |
To identify novel CRC biomarkers we utilized representational difference analysis (RDA) and characterized a colon cancer associated transcript (CCAT1), demonstrating consistently strong expression in adenocarcinoma of the colon, while being largely undetectable in normal human tissues (p < 000.1).
|
21547902 |
2012 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
BEFREE |
Taken together, CCAT1 is functionally involved in growth and metastasis of GC cells and it may be a potential target for GC therapy.
|
29940756 |
2018 |
|
Malignant neoplasm of stomach
|
0.370 |
AlteredExpression
|
disease |
BEFREE |
And high CCAT1 expression in GC tissues was associated with high tumor burden, including larger tumor size, lymphatic metastasis and advanced TNM stage (all p < 0.05).
|
28719351 |
2017 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
BEFREE |
Our findings implicated that CARLo-5 could be considered promising biomarkers for prognosis of gastric cancer.
|
28239816 |
2017 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
BEFREE |
Deregulation of CCAT1 (colon cancer-associated transcript-1), an oncogenic lncRNA, has been documented in different types of malignancy, such as gastric cancer, colorectal cancer and hepatocellular carcinoma.
|
27134049 |
2016 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
BEFREE |
CCAT1 has been reported to be linked with pathogenesis of malignancies including colon cancer and gastric cancer.
|
26225650 |
2015 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
BEFREE |
It has been reported that CCAT1 is involved in the development of malignancies including colon cancer and gastric cancer.
|
26191246 |
2015 |
|
Malignant neoplasm of stomach
|
0.370 |
Biomarker
|
disease |
BEFREE |
These results indicated that CARLo-5 might serve as a pro-oncogenic lncRNA that promotes proliferation of gastric cancer and activates the ERK/MAPK pathway.
|
25674211 |
2014 |
|
Colonic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
gallbladder neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Lung Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Pancreatic Neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Stomach Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |
|
Malignant neoplasm of gallbladder
|
0.300 |
Biomarker
|
disease |
CTD_human |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
|
26752646 |
2016 |